Product Code: GVR-4-68040-840-3
Ultrasound AI Market Overview
The global ultrasound AI market size was estimated at USD 1.82 billion in 2025 and is projected to reach USD 13.56 billion by 2033, growing at a CAGR of 28.55% from 2026 to 2033. Rising demand for accurate and early disease detection, rapid growth in imaging volumes, and government initiatives and regulatory support are significant factors contributing to market growth.
In addition, growing emphasis on cost-efficiency in healthcare delivery and technological advancements in machine learning, NLP, and computer vision are some other factors fueling market growth further.
The increasing demand for precise early disease detection is driving market growth. The rising global prevalence of cancer, cardiovascular, and neurological disorders underscores the need for advanced imaging to facilitate timely interventions. Moreover, AI-powered analysis is essential for identifying subtle anomalies that are likely to be overlooked during manual review. For instance, according to a meta-analysis of 18 studies published in the AJMC in December 2025, found ultrasound-based AI models diagnose ovarian cancer more accurately than sonographers, with an internal validation sensitivity/specificity of 0.95 and AUC 0.98 of 95% and external validation AUC 0.91 compared to sonographers exhibiting a sensitivity of 0.83 (95% CI, 0.62-0.94), a specificity of 0.84.
In addition, automated measurements and risk assessments enhance diagnostic reliability by reducing inconsistencies among radiologists and supporting personalized therapies. Recent developments, such as Exo's April 2024 FDA-cleared AI tools for heart failure and lung evaluation on the Exo Iris portable ultrasound, illustrate technological progress. The prioritization of value-based care further accelerates the integration of AI ultrasound solutions across healthcare systems.
Moreover, technological advancements in machine learning, natural language processing, and computer vision fuel the growth of AI in the ultrasound industry. Deep learning algorithms are improving in accuracy, enabling more reliable interpretation of complex imaging modalities. For instance, according to a study published in the Nature Scientific Reports Journal in January 2026, Researchers developed a deep learning model using squeeze-and-excitation capsule networks and convolutional bidirectional LSTM (CBLSTM) for diagnosing gallbladder diseases from ultrasound images. This approach analyzes sequences of frames to detect gallstones, cholecystitis, and other disorders with high accuracy, outperforming traditional manual methods.
Global Ultrasound AI Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global ultrasound AI market report based on component, application/modality, end use, and region:
- Component Outlook (Revenue, USD Million, 2021 - 2033)
- Hardware/ AI-enabled Devices
- Portable systems
- Cart-based systems
- Handheld ultrasound probes
- Software
- Services
- Application/Modality Outlook (Revenue, USD Million, 2021 - 2033)
- Cardiology / Echocardiography
- Radiology
- Obstetrics & Gynecology
- Urology
- Others
- End Use Outlook (Revenue, USD Million, 2021 - 2033)
- Hospitals
- Diagnostic Imaging Centers
- Ambulatory Surgical/Outpatient Centers
- Others
- Regional Outlook (Revenue, USD Million, 2021 - 2033)
- North America
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Thailand
- Latin America
- MEA
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Market Definitions
- 1.2.1. Component Segment
- 1.2.2. Application/Modality Segment
- 1.2.3. End Use
- 1.3. Information analysis
- 1.3.1. Market formulation & data visualization
- 1.4. Data validation & publishing
- 1.5. Information Procurement
- 1.6. Information or Data Analysis
- 1.7. Market Formulation & Validation
- 1.8. Market Model
- 1.9. Total Market: CAGR Calculation
- 1.10. Objectives
- 1.10.1. Objective 1
- 1.10.2. Objective 2
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Snapshot
- 2.3. Competitive Insights Landscape
Chapter 3. Ultrasound AI Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook.
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.1.1. Rising demand for accurate and early disease detection
- 3.2.1.2. Technological advancements in machine learning, natural language processing, and computer vision
- 3.2.1.3. Increasing government initiatives and regulatory support
- 3.2.2. Market restraint analysis
- 3.2.2.1. Data security and privacy concerns
- 3.2.2.2. High costs of advanced devices
- 3.2.3. Market opportunity analysis
- 3.2.4. Market challenges analysis
- 3.3. Case Studies
- 3.4. Ultrasound AI Market Analysis Tools
- 3.4.1. Industry Analysis - Porter's Five Forces Analysis
- 3.4.1.1. Supplier power
- 3.4.1.2. Buyer power
- 3.4.1.3. Substitution threat
- 3.4.1.4. Threat of new entrant
- 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
- 3.4.2.1. Political landscape
- 3.4.2.2. Technological landscape
- 3.4.2.3. Economic landscape
- 3.4.2.4. Environmental Landscape
- 3.4.2.5. Legal Landscape
- 3.4.2.6. Social Landscape
Chapter 4. Ultrasound AI Market: Component Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Global Ultrasound AI Market Component Movement Analysis
- 4.3. Global Ultrasound AI Market Size & Trend Analysis, by Component, 2021 to 2033 (USD Million)
- 4.4. Hardware/AI-enabled Devices
- 4.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
- 4.4.2. Portable systems
- 4.4.2.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
- 4.4.3. Cart-based systems
- 4.4.3.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
- 4.4.4. Handheld ultrasound probes
- 4.4.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
- 4.5. Software
- 4.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
- 4.6. Services
- 4.6.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 5. Ultrasound AI Market: Application/Modality Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Global Ultrasound AI Market Application/Modality Movement Analysis
- 5.3. Global Ultrasound AI Market Size & Trend Analysis, by Application/Modality, 2021 to 2033 (USD Million)
- 5.4. Cardiology / Echocardiography
- 5.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
- 5.5. Radiology
- 5.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
- 5.6. Obstetrics & Gynecology
- 5.6.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
- 5.7. Urology
- 5.7.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
- 5.8. Others
- 5.8.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 6. Ultrasound AI Market: End Use Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Global Ultrasound AI Market End Use Movement Analysis
- 6.3. Global Ultrasound AI Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
- 6.4. Hospitals (Large & Multi-Specialty)
- 6.4.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
- 6.5. Diagnostic Imaging Centers
- 6.5.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
- 6.6. Ambulatory Surgical / Outpatient Centers
- 6.6.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
- 6.7. Others
- 6.7.1. Market estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 7. Ultrasound AI Market: Regional Estimates & Trend Analysis
- 7.1. Regional Market Share Analysis, 2025 & 2033
- 7.2. Regional Market Dashboard
- 7.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
- 7.4. North America
- 7.4.1. U.S.
- 7.4.1.1. Key country dynamics
- 7.4.1.2. Regulatory framework
- 7.4.1.3. Competitive scenario
- 7.4.1.4. U.S. market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.4.2. Canada
- 7.4.2.1. Key country dynamics
- 7.4.2.2. Regulatory framework
- 7.4.2.3. Competitive scenario
- 7.4.2.4. Canada market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.4.3. Mexico
- 7.4.3.1. Key country dynamics
- 7.4.3.2. Regulatory framework
- 7.4.3.3. Competitive scenario
- 7.4.3.4. Mexico market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.5. Europe
- 7.5.1. UK
- 7.5.1.1. Key country dynamics
- 7.5.1.2. Regulatory framework
- 7.5.1.3. Competitive scenario
- 7.5.1.4. UK market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.5.2. Germany
- 7.5.2.1. Key country dynamics
- 7.5.2.2. Regulatory framework
- 7.5.2.3. Competitive scenario
- 7.5.2.4. Germany market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.5.3. France
- 7.5.3.1. Key country dynamics
- 7.5.3.2. Regulatory framework
- 7.5.3.3. Competitive scenario
- 7.5.3.4. France market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.5.4. Italy
- 7.5.4.1. Key country dynamics
- 7.5.4.2. Regulatory framework
- 7.5.4.3. Competitive scenario
- 7.5.4.4. Italy market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.5.5. Spain
- 7.5.5.1. Key country dynamics
- 7.5.5.2. Regulatory framework
- 7.5.5.3. Competitive scenario
- 7.5.5.4. Spain market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.5.6. Norway
- 7.5.6.1. Key country dynamics
- 7.5.6.2. Regulatory framework
- 7.5.6.3. Competitive scenario
- 7.5.6.4. Norway market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.5.7. Sweden
- 7.5.7.1. Key country dynamics
- 7.5.7.2. Regulatory framework
- 7.5.7.3. Competitive scenario
- 7.5.7.4. Sweden market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.5.8. Denmark
- 7.5.8.1. Key country dynamics
- 7.5.8.2. Regulatory framework
- 7.5.8.3. Competitive scenario
- 7.5.8.4. Denmark market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.6. Asia Pacific
- 7.6.1. Japan
- 7.6.1.1. Key country dynamics
- 7.6.1.2. Regulatory framework
- 7.6.1.3. Competitive scenario
- 7.6.1.4. Japan market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.6.2. China
- 7.6.2.1. Key country dynamics
- 7.6.2.2. Regulatory framework
- 7.6.2.3. Competitive scenario
- 7.6.2.4. China market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.6.3. India
- 7.6.3.1. Key country dynamics
- 7.6.3.2. Regulatory framework
- 7.6.3.3. Competitive scenario
- 7.6.3.4. India market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.6.4. Australia
- 7.6.4.1. Key country dynamics
- 7.6.4.2. Regulatory framework
- 7.6.4.3. Competitive scenario
- 7.6.4.4. Australia market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.6.5. South Korea
- 7.6.5.1. Key country dynamics
- 7.6.5.2. Regulatory framework
- 7.6.5.3. Competitive scenario
- 7.6.5.4. South Korea market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.6.6. Thailand
- 7.6.6.1. Key country dynamics
- 7.6.6.2. Regulatory framework
- 7.6.6.3. Competitive scenario
- 7.6.6.4. Thailand market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.7. Latin America
- 7.7.1. Brazil
- 7.7.1.1. Key country dynamics
- 7.7.1.2. Regulatory framework
- 7.7.1.3. Competitive scenario
- 7.7.1.4. Brazil market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.7.2. Argentina
- 7.7.2.1. Key country dynamics
- 7.7.2.2. Regulatory framework
- 7.7.2.3. Competitive scenario
- 7.7.2.4. Argentina market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.8. MEA
- 7.8.1. South Africa
- 7.8.1.1. Key country dynamics
- 7.8.1.2. Regulatory framework
- 7.8.1.3. Competitive scenario
- 7.8.1.4. South Africa market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.8.2. Saudi Arabia
- 7.8.2.1. Key country dynamics
- 7.8.2.2. Regulatory framework
- 7.8.2.3. Competitive scenario
- 7.8.2.4. Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.8.3. UAE
- 7.8.3.1. Key country dynamics
- 7.8.3.2. Regulatory framework
- 7.8.3.3. Competitive scenario
- 7.8.3.4. UAE market estimates and forecasts, 2021 - 2033 (USD Million)
- 7.8.4. Kuwait
- 7.8.4.1. Key country dynamics
- 7.8.4.2. Regulatory framework
- 7.8.4.3. Competitive scenario
- 7.8.4.4. Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)
Chapter 8. Competitive Landscape
- 8.1. Company/Competition Categorization
- 8.2. Strategy Mapping
- 8.3. Company Market Position Analysis, 2025
- 8.4. Company Profiles/Listing
- 8.4.1. Siemens Healthineers AG
- 8.4.1.1. Company overview
- 8.4.1.2. Financial performance
- 8.4.1.3. Product benchmarking
- 8.4.1.4. Strategic initiatives
- 8.4.2. GE HealthCare
- 8.4.2.1. Company overview
- 8.4.2.2. Financial performance
- 8.4.2.3. Product benchmarking
- 8.4.2.4. Strategic initiatives
- 8.4.3. Koninklijke Philips N.V.
- 8.4.3.1. Company overview
- 8.4.3.2. Financial performance
- 8.4.3.3. Product benchmarking
- 8.4.3.4. Strategic initiatives
- 8.4.4. EchoNous Inc.
- 8.4.4.1. Company overview
- 8.4.4.2. Financial performance
- 8.4.4.3. Product benchmarking
- 8.4.4.4. Strategic initiatives
- 8.4.5. Sonio SAS (a SAMSUNG Company)
- 8.4.5.1. Company overview
- 8.4.5.2. Financial performance
- 8.4.5.3. Product benchmarking
- 8.4.5.4. Strategic initiatives
- 8.4.6. Caption Care
- 8.4.6.1. Company overview
- 8.4.6.2. Financial performance
- 8.4.6.3. Product benchmarking
- 8.4.6.4. Strategic initiatives
- 8.4.7. UltraSight
- 8.4.7.1. Company overview
- 8.4.7.2. Financial performance
- 8.4.7.3. Product benchmarking
- 8.4.7.4. Strategic initiatives
- 8.4.8. Cardio.ai
- 8.4.8.1. Company overview
- 8.4.8.2. Financial performance
- 8.4.8.3. Product benchmarking
- 8.4.8.4. Strategic initiatives
- 8.4.9. SamsungHealthcare.com
- 8.4.9.1. Company overview
- 8.4.9.2. Financial performance
- 8.4.9.3. Product benchmarking
- 8.4.9.4. Strategic initiatives
- 8.4.10. Koios Medical
- 8.4.10.1. Company overview
- 8.4.10.2. Financial performance
- 8.4.10.3. Product benchmarking
- 8.4.10.4. Strategic initiatives
- 8.4.11. FUJIFILM Corporation
- 8.4.11.1. Company overview
- 8.4.11.2. Financial performance
- 8.4.11.3. Product benchmarking
- 8.4.11.4. Strategic initiatives
- 8.4.12. Clarius
- 8.4.12.1. Company overview
- 8.4.12.2. Financial performance
- 8.4.12.3. Product benchmarking
- 8.4.12.4. Strategic initiatives
- 8.4.13. Us2.AI
- 8.4.13.1. Company overview
- 8.4.13.2. Financial performance
- 8.4.13.3. Product benchmarking
- 8.4.13.4. Strategic initiatives